Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$191.17 - $325.63 $210,287 - $358,193
-1,100 Reduced 46.47%
1,267 $412,000
Q4 2023

Feb 14, 2024

BUY
$160.99 - $215.69 $10,786 - $14,451
67 Added 2.91%
2,367 $451,000
Q3 2023

Nov 09, 2023

SELL
$194.33 - $283.97 $97,165 - $141,985
-500 Reduced 17.86%
2,300 $458,000
Q2 2023

Aug 07, 2023

SELL
$223.05 - $302.68 $624,540 - $847,504
-2,800 Reduced 50.0%
2,800 $799,000
Q4 2022

Feb 08, 2023

BUY
$204.38 - $296.82 $1.14 Million - $1.66 Million
5,600 New
5,600 $1.15 Million

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Skandinaviska Enskilda Banken Ab (Publ) Portfolio

Follow Skandinaviska Enskilda Banken Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.